IPF

Neuro and inflammation biotech Contineum Therapeutics sets terms for $150 million IPO
Renaissance Capital
Mon, 04/1/24 - 12:25 pm
IPOs
Contineum Therapeutics
IPF
multiple sclerosis
Brainomix AI shows its worth in AZ pulmonary fibrosis trial
Pharmaphorum
Wed, 03/27/24 - 10:55 am
AstraZeneca
Brainomix
tralokinumab
IPF
artificial intelligence
Roche Reassesses Esbriet's Future Amidst Generic Drug Competition
Medriva
Tue, 02/27/24 - 11:28 am
Roche
generics
Esbriet
IPF
FibroGen plans new round of cost cuts after latest study setback
BioPharma Dive
Mon, 06/26/23 - 08:41 pm
FibroGen
IPF
pamvrelumab
clinical trials
First Human Trials Begin for AI-Designed Drug
The Daily Upside
Mon, 06/26/23 - 08:39 pm
Insilico
clinical trials
artificial intelligence
INS018_055
IPF
Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
IPF
Roche
Esbriet
Pirespa
Boehringer Ingelheim
Ofev
Bridge doses first patient in Phase lla trial of IPF therapy
Clinical Trials Arena
Thu, 04/13/23 - 11:55 am
Bridge Biotherapeutics
clinical trials
BBT-877
IPF
Promising IPF treatment results sent Pliant Therapeutics stock soaring
Investors Business Daily
Tue, 01/24/23 - 10:28 am
Pliant Therapeutics
clinical trials
IPF
bexotegrast
Digital therapeutic cuts IPF-related anxiety by half in pilot study
Pharmaphorum
Thu, 10/13/22 - 09:32 am
Alex Therapeutics
Medtech
digital therapeutics
anxiety
IPF
With new data, Pliant drug shows promise in tough-to-treat lung disease
BioPharma Dive
Mon, 07/11/22 - 10:28 am
Pliant Therapeutics
idiopathic pulmonary fibrosis
IPF
PLN-74809
clinical trials
Roche comes up short in its attempt to hold off generic competition to Esbriet
Endpoints
Thu, 03/24/22 - 08:38 pm
Roche
Esbriet
IPF
generics
The lung fibrosis pipeline thins
EP Vantage
Tue, 09/21/21 - 10:48 am
idiopathic pulmonary fibrosis
IPF
Pliant Therapeutics
PLN-74809
Liminal stops plan to advance fibrosis drug after seeing PK data
Fierce Biotech
Tue, 06/1/21 - 11:46 am
Liminal BioSciences
fezagrepas
IPF
clinical trials
Gilead's $5B Galapagos black hole widens as pair toss out phase 3 asset after flop
Fierce Biotech
Wed, 02/10/21 - 10:29 am
Gilead Sciences
Galapagos
IPF
ziritaxestat
With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug
Endpoints
Thu, 01/21/21 - 10:36 am
Roche
Esbriet
IPF
FDA
priority review
Citing toxicity concerns, Boehringer Ingelheim drops short-lived IPF pact — keeping $1B+ in its pocket
Endpoints
Wed, 11/11/20 - 11:07 am
Boehringer Ingelheim
IPF
Bridge Biotherapeutics
BBT-877
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward
Xconomy
Sun, 09/27/20 - 11:07 pm
Galecto Biotech
idiopathic pulmonary fibrosis
IPF
GB0139
Redx shares soar after IPF drug license deal with AstraZeneca
Pharmaforum
Tue, 08/4/20 - 10:58 am
Redx
AstraZeneca
IPF
RXC006
Boehringer debuts IPF songwriting contest with MLB player-turned-singer Bernie Williams
Fierce Pharma
Mon, 06/29/20 - 09:58 am
Boehringer Ingelheim
IPF
drug marketing
Lax Approval Requirements Yield Blockbusters That Don’t Work
Xconomy
Fri, 03/13/20 - 11:54 pm
FDA
drug approvals
conditional approvals
InterMune
Actimmune
IPF

Pages